Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial.
Saved in:
| Title: | Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial. |
|---|---|
| Authors: | Teng E; Early Clinical Development, Genentech Inc, South San Francisco, California., Manser PT; Biostatistics, Genentech Inc, South San Francisco, California., Pickthorn K; Early Clinical Development, Genentech Inc, South San Francisco, California., Brunstein F; Product Development Safety, Genentech Inc, South San Francisco, California., Blendstrup M; Clinical Operations, Genentech Inc, South San Francisco, California., Sanabria Bohorquez S; Clinical Imaging Group, Genentech Inc, South San Francisco, California., Wildsmith KR; Biomarker Development, Genentech Inc, South San Francisco, California.; Now with Eisai Inc, Woodcliff Lake, New Jersey., Toth B; Biostatistics, Genentech Inc, South San Francisco, California., Dolton M; Roche Products Pty Limited, Sydney, Australia., Ramakrishnan V; Clinical Pharmacology, Genentech Inc, South San Francisco, California., Bobbala A; Product Development Safety, Genentech Inc, South San Francisco, California., Sikkes SAM; Alzheimer Center Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center, VU University Amsterdam, Amsterdam, the Netherlands.; Department of Clinical, Neuro- and Developmental Psychology, VU University, Amsterdam, the Netherlands., Ward M; Early Clinical Development, Genentech Inc, South San Francisco, California.; Now with Alector Inc, South San Francisco, California., Fuji RN; Safety Assessment, Genentech Inc, South San Francisco, California., Kerchner GA; F. Hoffmann-La Roche AG, Basel, Switzerland. |
| Corporate Authors: | Tauriel Investigators |
| Source: | JAMA neurology [JAMA Neurol] 2022 Aug 01; Vol. 79 (8), pp. 758-767. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
